Understanding brain function through small vessel disease
What zebras can teach us about horses
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
So goes the adage attributed to Dr. Theodore Woodward of the University of Maryland. But perhaps considering the habits of zebras could teach us about their more common equine cousins. Traditionally, our knowledge about the correlation of normal structure and function in the brain has relied, to a large extent, on studying the disruption wrought by disease processes on normal function, whether this disrupted structure was detected at autopsy or more recently by CT and MRI. This led to the common dictum that neurology was learned “stroke by stroke” (lesion-symptom mapping). In the last 5 years, higher-resolution MRI scanners (3T and 7T machines) and innovative scanning protocols and analytic methods have exponentially expanded our ability to “see” subtle details of brain structure in living persons.1 In parallel, genetic studies have shown that mildly damaging genetic variants located within genes associated with severe monogenic disorders (“the diagnostic zebras”) may explain a larger proportion of common disease (“the horses”) than had been previously suspected. One example is NOTCH3, the gene underlying cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), variants within which are associated with greater white matter lesion load in healthy adults in the community.2
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 1946
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Multi-shell Diffusion MRI Models for White Matter Characterization in Cerebral Small Vessel DiseaseMarek J. Konieczny, Anna Dewenter, Annemieke ter Telgte et al.Neurology, November 16, 2020 -
Articles
Damage within a network of white matter regions underlies executive dysfunction in CADASILM. O’Sullivan, T. R. Barrick, R. G. Morris et al.Neurology, November 21, 2005 -
Articles
Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementiaMichael O’Sullivan, Sumeet Singhal, Rebecca Charlton et al.Neurology, March 08, 2004 -
Article
Strategic white matter tracts for processing speed deficits in age-related small vessel diseaseMarco Duering, Benno Gesierich, Stephan Seiler et al.Neurology, May 02, 2014